- Home
- U vs NBIX Comparison
U vs NBIX Comparison
Compare U & NBIX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- U
- NBIX
- Stock Information
- Founded
- U 2004
- NBIX 1992
- Country
- U United States
- NBIX United States
- Employees
- U N/A
- NBIX N/A
- Industry
- U Retail: Computer Software & Peripheral Equipment
- NBIX Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- U Technology
- NBIX Health Care
- Exchange
- U Nasdaq
- NBIX Nasdaq
- Market Cap
- U 15.2B
- NBIX 14.4B
- IPO Year
- U 2020
- NBIX 1996
- Fundamental
- Price
- U $37.39
- NBIX $138.96
- Analyst Decision
- U Buy
- NBIX Strong Buy
- Analyst Count
- U 19
- NBIX 18
- Target Price
- U $36.52
- NBIX $172.33
- AVG Volume (30 Days)
- U 10.4M
- NBIX 1.2M
- Earning Date
- U 11-05-2025
- NBIX 10-28-2025
- Dividend Yield
- U N/A
- NBIX N/A
- EPS Growth
- U N/A
- NBIX 12.44
- EPS
- U N/A
- NBIX 4.19
- Revenue
- U $1,803,658,000.00
- NBIX $2,682,700,000.00
- Revenue This Year
- U $1.59
- NBIX $23.68
- Revenue Next Year
- U $10.53
- NBIX $18.02
- P/E Ratio
- U N/A
- NBIX $33.07
- Revenue Growth
- U N/A
- NBIX 19.61
- 52 Week Low
- U $15.33
- NBIX $84.23
- 52 Week High
- U $46.94
- NBIX $157.67
- Technical
- Relative Strength Index (RSI)
- U 46.76
- NBIX 41.83
- Support Level
- U $34.79
- NBIX $145.00
- Resistance Level
- U $37.63
- NBIX $148.84
- Average True Range (ATR)
- U 2.43
- NBIX 5.03
- MACD
- U -0.19
- NBIX -0.99
- Stochastic Oscillator
- U 26.68
- NBIX 10.68
About U Unity Software Inc.
Unity Software Inc provides a software platform for creating and operating interactive, real-time 3D content. The platform can be used to create, run, and monetize interactive, real-time 2D and 3D content for mobile phones, tablets, PCs, consoles, and augmented and virtual reality devices. The business is spread across the United States, Greater China, EMEA, APAC, and other Americas, and key revenue is derived from the EMEA region. The products are used in the gaming industry, retail, automotive, architecture, engineering, and construction.
About NBIX Neurocrine Biosciences Inc.
Neurocrine Biosciences Inc engages in the discovery, development, and commercialization of drugs for the treatment of neurological and endocrine-related diseases and disorders in the United States. The company's products include INGREZZA for tardive dyskinesia and chorea associated with Huntington's disease; ALKINDI for adrenal insufficiency; Efmody capsules for classic congenital adrenal hyperplasia; Orilissa tablets for endometriosis; and Oriahnn capsules to treat uterine fibroids.